Sugar Palm Fruits (Arenga pinnata) as Potential Analgesics and Anti-Inflammatory Agent
Journal: Molecular and Cellular Biomedical Sciences (Vol.3, No. 2)Publication Date: 2019-09-01
Authors : Evi Sovia Dian Anggraeny;
Page : 107-14
Keywords : Arenga pinnata; analgesic; anti-inflammatory; acute toxicity;
Abstract
Background: Sugar palm fruit (Arenga pinnata) is used for osteoarthritis empirically. It also has antioxidant activity and showed inhibition to lipoxygenase activity. The study about analgesic and anti-inflammatory activities of sugar palm fruit is still limited, this study was initiated to explore analgesic and anti-inflammatory effects of sugar palm fruit ethanol extract (SFEE). Materials and Methods: Acetic acid induced writhing was performed for screening analgesic activity, meanwhile antiinflammatory activity was tested against rat paw edema. Acute toxicity and phytochemical screening were also investigated. Results: The results of phytochemical screening revealed that flavonoids, alkaloids and quinones were present in SFEE. SFEE 50 and 100 mg/kg have analgesic effect and show the anti-oedematogenic effect against paw edema induced by carrageenan. SFEE could significantly decrease the neutrophils numbers as compared to the carrageenan-treated group. Neutrophil activation has been shown to contribute to tissue inflammation and damage. Conclusion: SFEE have analgetic and anti-inflammatory activity.
Other Latest Articles
- ANALYSIS OF NON-STRUCTURAL BRICK WALLS IN THE FORMER DAJTI HOTEL BUILDING, TIRANA, ALBANIA
- Antioxidant Effects of Red Fruit Oil on MMP-1 Gene Expression and Malondialdehyde Levels on Skin Exposed to UVB Rays
- The Difference of Bax Protein Expression between Endometrioma and Ovarian Carcinoma
- Association between Hasford Scoring System and Hematologic Response in Chronic and Accelerated Phase of Chronic Myelocytic Leukemia Patient with Imatinib for Three Months
- ESTIMATION OF AVERAGE ANNUAL COMMITTED EFFECTIVE DOSE DUE TO INGESTION FOR SOME MEDICINAL AND HERBAL PLANTS USED IN ALBANIA
Last modified: 2020-07-02 12:27:27